<DOC>
	<DOCNO>NCT02834234</DOCNO>
	<brief_summary>Peritoneal mesothelioma rare disease represent one third mesothelioma nothing know molecular characteristic disease . As main cancer , genetic heterogeneity probable . This genomic profiling associate Comparative Genomic Hybridization ( CGH ) array , BAP1 sequence gene expression order discover biomarker could use treatment rare disease . Corresponding histopathological immunohistochemical report clinical data available . All data merge underline gene interest focus next investigation . Depending preliminary result , BAP1 mutation expect , also describe pleural mesothelioma . Mutations oncogenic driver could target specific therapy particular interest management rare disease bad prognosis .</brief_summary>
	<brief_title>Genomic Analysis Peritoneal Mesothelioma CGH Arrays</brief_title>
	<detailed_description />
	<mesh_term>Mesothelioma</mesh_term>
	<criteria>surgical biopsy od peritoneal tumor frozen sample age &gt; 18 year old absence peritoneal mesothelioma absence frozen sample</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>mesothelioma</keyword>
	<keyword>peritoneum</keyword>
	<keyword>genomic</keyword>
	<keyword>CGH array</keyword>
</DOC>